|
End-of-day quote
Buenos Aires S.E.
09/09/2026
|
5-day change | 1st Jan Change | ||
| 19,360.00 ARS | 0.00% |
|
-3.49% | +3.58% |
| 09/09 | GSK plc Presents at Bernstein?s 23rd Annual Pan-European Strategic Decisions Conference, Sep-09-2026 08:00 AM | |
| 09/09 | The Fed's September Squeeze |  |
| Market Cap | 7.23TCr 1,48,20200Cr 9.79TCr 8.42TCr 7.93TCr 14TCr 9,31500Cr 14TCr 94TCr 36TCr 4,74500Cr 37TCr 36TCr 15,03300Cr | P/E 2026 * |
13.8x | P/E 2027 * | 11.3x |
|---|---|---|---|---|---|
| Enterprise Value | 9.3TCr 1,90,70000Cr 13TCr 11TCr 10TCr 17TCr 11,98600Cr 17TCr 1,21000Cr 47TCr 6,10600Cr 47TCr 46TCr 19,34400Cr | EV / Sales 2026 * |
2.74x | EV / Sales 2027 * | 2.54x |
| Free-Float |
92.75% | Yield 2026 * |
3.86% | Yield 2027 * | 4.16% |
| Markets | Quality | ||
|---|---|---|---|
Buenos Aires S.E.
| GSK | End-of-day quote | |
Buenos Aires S.E.
| GSKD | End-of-day quote |
Last Transcript : GSK plc
| 1 week | -3.49% | ||
| Current month | -3.68% | ||
| 1 month | -7.72% | ||
| 3 months | +0.10% | ||
| 6 months | -4.63% | ||
| Current year | +3.58% |
| 1 week | 19,280 |  | 20,500 |
| 1 month | 19,280 | | 20,940 |
| Current year | 17,020 | | 22,760 |
| 1 year | 13,680 | | 22,760 |
| 3 years | 6,706.5 | | 22,760 |
| 5 years | 2,171.5 | | 22,760 |
| 10 years | 543.12 | | 22,760 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | 52 | 01/01/2026 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 01/05/2023 |
James Ford
CMP | Compliance Officer | - | 01/08/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | 52 | 06/05/2026 |
Hal Barron
BRD | Director/Board Member | 64 | 01/01/2018 |
Jonathan Symonds
CHM | Chairman | 67 | 01/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -3.49% | - | - | 9.79TCr | |
| +0.03% | -3.09% | +49.77% | +91.69% | 1,00200Cr | |
| -0.76% | -2.95% | +50.93% | +66.34% | 64TCr | |
| +0.86% | -4.13% | +19.24% | +68.37% | 44TCr | |
| -0.80% | -0.43% | +28.92% | +35.45% | 34TCr | |
| -0.13% | -14.97% | +9.41% | +26.71% | 26TCr | |
| -1.90% | -2.72% | -2.72% | +7.41% | 24TCr | |
| -0.48% | -11.65% | +39.75% | +50.82% | 21TCr | |
| -1.06% | -4.23% | -14.70% | -57.36% | 20TCr | |
| -0.68% | -2.65% | +25.82% | +91.64% | 18TCr | |
| Average | -0.51% | -5.00% | +22.94% | +42.34% | 39.22TCr | |
| Weighted average by Cap. | -0.40% | -4.24% | +32.03% | +57.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.39TCr 69,62100Cr 4.6TCr 3.96TCr 3.73TCr 6.35TCr 4,37600Cr 6.38TCr 44TCr 17TCr 2,22900Cr 17TCr 17TCr 7,06200Cr | 3.55TCr 72,78400Cr 4.81TCr 4.14TCr 3.9TCr 6.64TCr 4,57500Cr 6.67TCr 46TCr 18TCr 2,33000Cr 18TCr 18TCr 7,38300Cr |
| Net income | 538.05Cr 11,03400Cr 728.8Cr 627.14Cr 590.51Cr 1.01TCr 69TCr 1.01TCr 7TCr 2.7TCr 35TCr 2.74TCr 2.68TCr 1,11900Cr | 637.41Cr 13,07200Cr 863.39Cr 742.95Cr 699.55Cr 1.19TCr 82TCr 1.2TCr 8.29TCr 3.2TCr 42TCr 3.24TCr 3.17TCr 1,32600Cr |
| Net Debt | 2.07TCr 42,49900Cr 2.81TCr 2.42TCr 2.27TCr 3.88TCr 2,67100Cr 3.89TCr 27TCr 10TCr 1,36100Cr 11TCr 10TCr 4,31100Cr | 1.8TCr 36,88400Cr 2.44TCr 2.1TCr 1.97TCr 3.37TCr 2,31800Cr 3.38TCr 23TCr 9.04TCr 1,18100Cr 9.15TCr 8.95TCr 3,74100Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/26/09 | ARS 19,360.00 | 0.00% | 123 |
| 08/26/08 | ARS 19,360.00 | -2.71% | 762 |
| 07/26/07 | ARS 19,900.00 | +0.71% | 79 |
| 04/26/04 | ARS 19,760.00 | -2.03% | 202 |
| 03/26/03 | ARS 20,170.00 | +0.55% | 2,298 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
- GSK Stock
Select your edition
All financial news and data tailored to specific country editions
